Dra. Laura Domingo Rodriguez

Institutions of which it is part

PhD in Biomedicine with extensive experience in the neuroscience field as a preclinical researcher and complemented as a Clinical Trials Study Coordinator in Movement Disorders unit - VHIR . I am proactive, fast-learning, and well-organized professional. Comfortable working autonomously and in a multidisciplinary teamwork environment. Proven ability to manage with several responsibilities in a fast-paced environment with critical deadlines. I am always motivated to embrace new challenges in my job.


- Clinical Trials Study Coordinator
Movement Disorders Unit - Vall d’Hebron Institute of Research (VHIR) | Sep 2020

- Postdoctoral Researcher in Neuroscience
Neuropharmacology Lab, UPF | Jan - Jun 2020

- PhD Researcher in Biomedicine | Neuroscience
Neuropharmacology Lab, UPF | Sept 2015 - Jan 2020

- University teacher of Psychology of human behavior
UAB Study Abroad Program | Jul 2017 - Jul 2019

- Master's degree in Clinical Trial Monitoring and Pharmaceutical Development
INESEM Business School | Jul 2020 - Jan 2021

- PhD in Biomedicine (Excellent cum laude)
Neuropharmacology Lab, UPF | Sept 2015 - Jul 2020

- Master’s degree in Neuroscience
Barcelona University | Sept 2014 - Jul 2015

- Bachelor’s degree in Human Biology
Pompeu Fabra University (UPF) | Sept 2010 - Jun 2014

- Good Clinical Practice (GCP)
The National Institute on Drug Abuse (NIDA)| May 2020

- Advanced Certificate inEnglish (C1)

- Domingo-Rodriguez L, Ruiz de Azua I, Dominguez E, Senabre E, Serra I, Kummer S, Navandar M, Baddenhausen S, Hofmann C, Andero R, Gerber S, Navarrete M, Dierssen M, Lutz B, Martín-García E, Maldonado R. A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction. Nat Commun. 2020 Feb 7;11(1):782.

- Martín-García E, Domingo-Rodriguez L, Maldonado R. An Operant Conditioning Model Combined with a Chemogenetic Approach to Study the Neurobiology of Food Addiction in Mice. Bio Protoc. 2020 Oct 5;10(19):e3777.

- Ruiz de Azua I, Martin-Garcia E, Domingo-Rodriguez L, Aparisi Rey A, Pascual Cuadrado D, Islami L, Turunen P, Remmers F, Lutz B, Maldonado R. Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons drives overconsumption of palatable food and obesity. Neuropsychopharmacology. 2021 Apr;46(5):982-991.

- Maldonado R, Calvé P, García-Blanco A, Domingo-Rodriguez L, Senabre E, Martín-García E. Vulnerability to addiction. Neuropharmacology. 2021 Mar 15;186:108466.

- Maldonado R, Calvé P, García-Blanco A, Domingo-Rodriguez L, Senabre E, Martín-García E. Genomics and epigenomics of addiction. Am J Med Genet B Neuropsychiatr Genet. 2021
Laura Domingo Rodriguez

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.